Concepedia

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience

Aristotelis Bamias, Alexandra Karadimou, Nikolaos Soupos, Maria Sotiropoulou, Flora Zagouri, Dimitrios Haidopoulos, Nikolaos Thomakos, Alexandros Rodolakis, A. Antsaklis, Meletios Α. Dimopoulos

Gynecologic Oncology · 2011 · 17 citations · 27 references

DOI

Concepts

References

27

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2K citations

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

Robert J. Kurman, Ie‐Ming Shih · The American Journal of Surgical Pathology · 2010 · 1.8K citations · Full text

, , +15

Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results

M. Piccart · JNCI Journal of the National Cancer Institute · 2000 · 1K citations · Full text

Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

William E. Winter, G. Larry Maxwell, Chunqiao Tian et al. · Journal of Clinical Oncology · 2007 · 839 citations · Full text